Home / Annual Review 2018 – 2019 / Supporting Growth / Advent seals EUR 1.9bn Zentiva deal as healthcare...
  1. Innovation
    1. Davos: winning trust in a digitalised, connected world
    2. Using technology to serve our clients
    3. Finding the balance: human touch versus high tech
    4. Connected Future: a global infrastructure report
    5. ShopBack seals latest major fundraising in Singapore
    6. FinTech reshapes financial services as sector booms
    7. WeWork: pioneering a new way of office working
  2. Anticipation
    1. Portuguese renewable energy sector heats up with EUR 600m Novenergia sale
    2. Coty picks CMS as global adviser following beauty parade
    3. Tristan completes EPISO 5 fund raise amidst political turbulence
    4. New challenges in a changing world
    5. E-Procurement sets new commercial tone for EU contractors
  3. Supporting Growth
    1. Cinven acquires PPF as European pet food market flourishes
    2. Advance takes centre stage with theatre group acquisition
    3. Advent seals EUR 1.9bn Zentiva deal as healthcare booms
    4. Liberty sells European assets to Vodafone in EUR 18.4bn mega-deal
  4. Managing Risk
    1. New lab services agreements for Honeywell following Homes spin-off
    2. Creating a tax-effective structure for a private equity investment
    3. Protecting trade marks across Europe
    4. Markel takes Hippo to task in complex insurance arrears dispute
    5. Climate change liability – new litigation risks
  5. Inside CMS
    1. From China to Chile: cultural differences and the ties that bind
    2. Facing the future
    3. CMS breaks ground with first global tech start up programme, equIP
  6. CSR and Diversity & Inclusion
    1. Helping to achieve a better world
  7. Interviews
    1. Interview with Olga Belyakova
    2. Interview with Jeremy Tan
    3. Interview with Laura Houet
    4. Interview with Ramón Huapaya
    5. Interview with Daniela Murer
    6. Interview with Christopher Jordan
    7. Interview with Herman Boersen
    8. Interview with Sibylle Schnyder
    9. Interview with Clemens Grossmayer
    10. Interview with Robert Stephen
    11. Interview with Mary Allan
    12. Interview with Matias Somarriva
    13. Interview with Denis Redon
    14. Interview with Joaquim Sherman de Macedo
    15. Interview with Eleanor Lane
    16. Interview with Niklas Zaugg
    17. Interview with Joachim Kaetzler
    18. Interview with Andreas Otto

Advent seals EUR 1.9bn Zentiva deal as healthcare booms

"Our Life Sciences & Healthcare sector knowledge and significant experience in private equity and pharma M & A, as well as our ability to operate across borders, were key to the success of the transaction."
Partner Life Sciences & Healthcare CMS Sofia

The past year has seen a frenzy of buyout activity in the healthcare sector, with private equity houses focusing closely on the sector.

A combination of inexpensive corporate debt finance, strong and growing revenue streams in the healthcare sector and the trend for healthcare companies to spin off non-core assets have all contributed  to the boom.

In a major deal for the sector, global private equity house Advent International acquired Zentiva, Sanofi’s European generic pharmaceuticals business, for EUR 1.9bn.

Headquartered in Prague, Zentiva has operations throughout Europe. Advent has extensive experience in executing corporate carve-outs and will support Zentiva as it enters a new phase of its history as an independent business.

A cross-border CMS team of over 50 lawyers advised Advent across the Czech Republic, Hungary, Poland, Romania, Slovakia and Switzerland, with the deal coordinated out of our Sofia and London offices.

CMS Sofia and Advent Relationship Partner David Butts said, “Our Life Sciences & Healthcare sector knowledge and significant experience in private equity and pharma M&A, as well as our ability to operate across borders, were key to the success of the transaction, from the initial due diligence to the various local restructurings required to effect the pre-completion carve-out and assistance on the financing aspects.” CMS teams  also worked on the CEE aspects of the acquisition financing.

He added, “We worked across seven jurisdictions, often at weekends and within very tight timescales. This is an extremely competitive sector and being able to deliver consistent, commercial advice is key.” Various workstreams continue to be active beyond completion, including in respect of Zentiva’s first bolt-on acquisition as an Advent portfolio company.